Work

Guard-01: A randomized, open-label trial of efbemalenograstim alfa as primary prophylaxis for neutropenia during definitive concurrent chemo-radiotherapy.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.12060

Authors: Yuanyuan Chen, QiWen Li, Zunbei Wen, Yi Ouyang, Yongling Ji, Rong Huang, Shuzhen Lai, Chen Wang, Min Ying Li, Qingren Lin, Xuefang Zhang, Ming Chen

Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Gaozhou People's Hospital, Zhejiang Cancer Hospital, First People's Hospital of Foshan, Shantou University, Yue Bei People's Hospital, Ganzhou People's Hospital, Zhongshan People's Hospital, Dongguan People’s Hospital

Language: English

Topic: Neutropenia and Cancer Infections

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162536562

Cites:

Cited by:

Related to: